Therapy Insight: venous-catheter-related thrombosis in cancer patients
- PMID: 16596145
- DOI: 10.1038/ncponc0458
Therapy Insight: venous-catheter-related thrombosis in cancer patients
Abstract
Central venous catheters (CVCs) have improved the management of patients with cancer substantially, by facilitating chemotherapy and supportive therapy. The use of CVCs is associated with complications such as infection and upper-limb deep vein thrombosis (UL-DVT). The incidence of clinically overt UL-DVT related to the use of CVCs ranges between 2% and 4%. In the most recent study, the incidence of CVC-related thrombosis, as screened by venography, was approximately 18% in the absence of prophylaxis. In cancer patients with CVC-related UL-DVT, the incidence of clinically overt pulmonary embolism was between 15% and 25%, and the incidence of autopsy-proven pulmonary embolism was up to 50%. Pathogenic factors for CVC-related thrombosis include vessel injury caused by the CVC insertion procedure, venous stasis because of the indwelling CVC, and hypercoagulability associated with cancer. Recent studies have not confirmed a benefit for prophylaxis with antithrombotic agents for CVC-related thrombosis. The recommended treatment for CVC-related thrombosis is based on long-term anticoagulant therapy, with or without catheter removal.
Similar articles
-
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.J Clin Oncol. 2003 Oct 1;21(19):3665-75. doi: 10.1200/JCO.2003.08.008. J Clin Oncol. 2003. PMID: 14512399 Review.
-
[Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].Pathol Biol (Paris). 2008 Jun;56(4):211-9. doi: 10.1016/j.patbio.2008.02.002. Epub 2008 Apr 18. Pathol Biol (Paris). 2008. PMID: 18395994 Review. French.
-
Catheter-related deep venous thrombosis and other catheter complications in children with cancer.J Clin Oncol. 2006 Oct 1;24(28):4575-80. doi: 10.1200/JCO.2005.05.5343. J Clin Oncol. 2006. PMID: 17008698
-
Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.Br J Haematol. 2005 Jun;129(6):811-7. doi: 10.1111/j.1365-2141.2005.05529.x. Br J Haematol. 2005. PMID: 15953009
-
Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer.Cancer. 2010 Sep 1;116(17):4197-205. doi: 10.1002/cncr.25199. Cancer. 2010. PMID: 20533566
Cited by
-
Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer.Support Care Cancer. 2018 Jan;26(1):81-89. doi: 10.1007/s00520-017-3816-3. Epub 2017 Jul 29. Support Care Cancer. 2018. PMID: 28756472
-
Disconnection of chamber and catheter as a complication of central venous catheter type port-a-cath.Med Oncol. 2011 Dec;28(4):1176-9. doi: 10.1007/s12032-010-9615-z. Epub 2010 Jul 7. Med Oncol. 2011. PMID: 20607455
-
Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved?Support Care Cancer. 2014 Jun;22(6):1705-14. doi: 10.1007/s00520-014-2208-1. Support Care Cancer. 2014. PMID: 24659216 Review.
-
Pathogenesis, clinical and laboratory aspects of thrombosis in cancer.J Thromb Thrombolysis. 2007 Aug;24(1):29-38. doi: 10.1007/s11239-007-0028-6. Epub 2007 Mar 31. J Thromb Thrombolysis. 2007. PMID: 17396228 Review.
-
5-fu metabolism in cancer and orally-administrable 5-fu drugs.Cancers (Basel). 2010 Sep 17;2(3):1717-30. doi: 10.3390/cancers2031717. Cancers (Basel). 2010. PMID: 24281184 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical